-
The Use of Social Media Listening to Collect Oncology-Specific Patient Experience Data: A Scoping Review
Mar 10, 2025, 14:00 PM -
Disparities in Tardive Dyskinesia Diagnosis and Treatment Among the US Medicare Population
Mar 10, 2025, 14:00 PM -
Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints
Mar 10, 2025, 14:00 PM -
Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma
Mar 10, 2025, 14:00 PM -
Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Healthcare Resource U tilization and Healthcare Costs After Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The ENDURE Study
Mar 10, 2025, 14:00 PM -
Early Detection of CHAPLE Disease in Pediatric Protein-Losing Enteropathy: A Feasibility Study
Mar 10, 2025, 14:00 PM -
Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation
Mar 10, 2025, 14:00 PM -
Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
Mar 10, 2025, 14:00 PM -
Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil
Mar 10, 2025, 14:00 PM -
Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization (HCRU) and Costs of Poly(ADP-ribose) Polymerase Inhibitors (PARPi) as First-Line Maintenance (1LM) Treatment for Ovarian Cancer (OC)
Mar 10, 2025, 14:00 PM -
Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab in 1L Recurrent/Metastatic Head and Neck Squamous Cell Cancer (R/M HNSCC) in Brazil
Mar 10, 2025, 14:00 PM -
Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring
Mar 10, 2025, 14:00 PM -
Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis
Mar 10, 2025, 14:00 PM -
Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention
Mar 10, 2025, 14:00 PM -
Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD
Mar 10, 2025, 14:00 PM -
Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology
Mar 10, 2025, 14:00 PM
